Related Experiment Videos
[Vasoactive polypeptide-producing pancreatic carcinoma]
Orvosi Hetilap
|September 10, 1995
Summary
Verner-Morrison syndrome in a 75-year-old man was caused by a pancreatic VIP-oma. While octreotide treatment was effective, the patient died from pulmonary embolism.
Area of Science:
- Endocrinology
- Oncology
- Gastroenterology
Background:
- Verner-Morrison syndrome is a rare condition characterized by severe diarrhea, hypokalemia, and gastric acid hypersecretion.
- It is typically caused by a neuroendocrine tumor, most commonly a VIP-oma (vasoactive intestinal peptide-producing tumor).
Observation:
- A 75-year-old male presented with symptoms consistent with Verner-Morrison syndrome.
- The underlying cause was identified as a pancreatic VIP-oma with an adenocarcinoma histological structure.
Findings:
- Treatment with the somatostatin analog octreotide provided symptomatic relief.
- Despite effective tumor management, the patient experienced a fatal outcome due to pulmonary embolism.
Implications:
- This case highlights the importance of early diagnosis and management of VIP-omas.
- It underscores the potential for severe complications, such as pulmonary embolism, even with effective symptomatic treatment.
- Pancreatic neuroendocrine tumors require a multidisciplinary approach for optimal patient outcomes.